Search research articles
Contact Us
Filters
Showing results (161-170 of 223) with videos related to
Page
of 23
Sort By:
Magnetic Resonance in Medicine
|
October 31, 2018
Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients
Jeremy W Gordon, Hsin-Yu Chen, Adam Autry, et al.
Molecular Cancer Research : MCR
|
June 9, 2017
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer
Rahul Aggarwal, Spencer C Behr, Pamela L Paris, et al.
Theranostics
|
February 23, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2025
Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study
Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier, et al.
Urologic Oncology
|
November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Vivek Narayan, Michael Harrison, Heather Cheng, et al.
ACS Chemical Biology
|
April 8, 2020
A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography
Yangjie Huang, Ning Zhao, Yung-Hua Wang, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Urologic Oncology
|
July 26, 2021
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study
YaoYao Pollock, Li Zhang, Stacey A Kenfield, et al.
JCO Precision Oncology
|
July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing
Emmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies
Pamela Munster, Rahul Aggarwal, David Hong, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 223) with videos related to
Sort By:
Page
of 23
Magnetic Resonance in Medicine
|
October 31, 2018
Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients
Jeremy W Gordon, Hsin-Yu Chen, Adam Autry, et al.
Molecular Cancer Research : MCR
|
June 9, 2017
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer
Rahul Aggarwal, Spencer C Behr, Pamela L Paris, et al.
Theranostics
|
February 23, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2025
Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study
Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier, et al.
Urologic Oncology
|
November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Vivek Narayan, Michael Harrison, Heather Cheng, et al.
ACS Chemical Biology
|
April 8, 2020
A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography
Yangjie Huang, Ning Zhao, Yung-Hua Wang, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Urologic Oncology
|
July 26, 2021
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study
YaoYao Pollock, Li Zhang, Stacey A Kenfield, et al.
JCO Precision Oncology
|
July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing
Emmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies
Pamela Munster, Rahul Aggarwal, David Hong, et al.
Page
of 23